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Abstract
Introduction
Men who have sex with men and transgender individuals (MSM/TG) carry a disproportion-
ately high burden of HIV, including in South Africa. However, there are few empirical popula-
tion-representative estimates of viral suppression and the HIV care cascade including HIV
testing among this population, nor of factors associated with these outcomes.
Methods
We conducted a respondent driven sampling (RDS) survey among 301 MSM/TG in Johan-
nesburg in 2017. Participants gave blood samples for HIV testing and viral load. Participants
self-completed a survey including sociodemographics, HIV testing history, and engagement
in care. We calculated RDS-II weighted estimates of the percentage of HIV-negative MSM/
TG reporting HIV testing in the previous 6 months, their testing experience and preferences.
Among those HIV-positive, we estimated the percentage status-aware, on ART, and virally
suppressed (<50 viral copies/ml plasma). We conducted RDS-weighted robust Poisson
regression to obtain weighted prevalence ratios of factors associated with 1) HIV testing
among those HIV-negative; and 2) viral suppression among those HIV-positive.
Results
There were 118/300 HIV-positive MSM/TG, (37.5%). Of the HIV-negative MSM/TG, 61.5%
reported that they had tested for HIV in the previous 6 months, which was associated with
selling sex to men (Prevalence Ratio = 1.67, 95% CI 1.36–2.05). There were 76/118 HIV-
positive MSM/TG (56.5%) who reported having previously tested positive for HIV and 39/
118 (30.0%) who reported current ART. There were 58/118 HIV-positive MSM/TG with viral
loads <50 copies/ml plasma (46.9%). Viral suppression was associated with older age
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Conclusions
HIV prevalence was very high. Viral suppression among those HIV-positive was similar to
the general male population in South Africa, but remains far short of national and interna-
tional targets. A majority of HIV-negative MSM/TG had HIV tested in the previous 6 months,
though there is room for improvement.
Introduction
HIV surveillance and programming targeting gay and bisexual men, other men who have sex
with men and transgender women (MSM/TG) have until recently been neglected in countries
with generalised HIV epidemics[1]. Over the last ten years, this has begun to change, with
increasing funder and policymaker attention paid to the burden of HIV experienced by these
populations[2–4], including in South Africa’s National Strategic Plan for HIV, TB and STI’s
[5]. Over this same period, coverage of antiretroviral treatment (ART) in sub-Saharan Africa
has greatly expanded and AIDS-related mortality in general populations has fallen dramati-
cally[6, 7]. Effective treatment to achieve viral suppression also avoids sexual transmission of
the virus, including among MSM[8], and at the population level, ‘Treatment as Prevention’
(TasP) has the potential to reduce HIV incidence[9, 10]. Accordingly, UNAIDS set ‘care cas-
cade’ targets specifying that of all HIV-positive individuals in a given population, 90% should
be aware of their status, 90% of those aware should be on antiretroviral treatment (ART) and
90% of those on ART should be virally suppressed by 2020[11].
Targets have not yet been reached in South Africa: among all males aged 15 years and
above in Gauteng Province, 85% of those HIV-positive were estimated to be aware of their sta-
tus, 43% on ART and 34% virally suppressed in 2017[12]. A modelling study for Johannesburg
estimated that among people aged 15 and older living with HIV in 2016, 73% were aware of
their status, 45% on ART and 26% virally suppressed[13], indicating large gaps between diag-
nosis and access to treatment. It is possible, however, that the cascade for MSM and transgen-
der populations differs substantially, but to date little empirical population-representative
evidence from sub-Saharan Africa has been published to offer insight[14–18].
Experiences of violence, harassment, and stigma routinely inhibit MSM/TG’s access to
healthcare[19, 20]. While same-gender sex is legally protected in South Africa, MSM/TG nev-
ertheless face societal discrimination[21]. There is concern that stigma and discrimination
toward MSM/TG may pose barriers to prompt diagnosis, linkage to and retention in care, and
adherence to ART, leading to worse HIV care outcomes. Stigma might act differentially across
the cascade; there could be more pressure to disclose sexual orientation at the point of HIV
testing than at the point of treatment initiation or follow-up. A study of MSM and other men
attending two ‘Health4Men’ MSM-friendly clinics in Johannesburg found no evidence for a
difference in ART retention after 24 months among men reporting same sex behaviour and
those not[22], but it is unknown whether the same would be found for clinics not specifically
tailoring for the needs of MSM/TG.
Prompt initiation of HIV care necessarily depends upon uptake and frequency of HIV test-
ing, which itself may be inhibited due to stigma. MSM/TG who initially test HIV-negative
need to test repeatedly during periods at risk. Men in South Africa test less frequently than
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women[23], while MSM could be further inhibited due to aforementioned healthcare-related
stigma. A qualitative study among urban MSM found that HIV testing was often viewed as a
one-off requirement[24]. While there is historical evidence of low testing rates among South
African MSM[25], testing appears to have increased between 2008 and 2013, concordant with
increasing provision of MSM programming[26] and increases in HIV testing amongst men as
a whole during this period[27]. There is a need now for up-to-date estimates and preferences
for HIV testing among MSM/TG.
To inform HIV prevention and care programming, the TRANSFORM study set out to pro-
vide population-representative empirical estimates and correlates of the HIV care cascade and
viral suppression among HIV-positive MSM/TG, and recency of and preferences for HIV test-
ing among HIV-negative MSM/TG in Johannesburg, and to explore characteristics associated
with these outcomes and behaviours.
Methods
Population
Eligibility criteria included being aged 18 years or older; male gender assigned at birth or cur-
rent male identity; sex with a man in the past 12 months; and resident in Johannesburg.
Sampling and recruitment
To obtain representative estimates, we recruited participants using respondent-driven sam-
pling (RDS) [28], informed by formative research conducted within the TRANSFORM study.
Recruitment proceeded in ‘waves’ with two coupons valid for two weeks issued to each partici-
pant, except when nearing the target sample size when we reduced to one coupon. Participants
were reimbursed ZAR 150 for participation in the study and received ZAR 150 for each
recruitee.
Data collection
Recruitment began in April 2017 with four seed participants, with five additional seeds added
until September 2017. Following eligibility screening and informed consent, participants pri-
vately completed a self-administered survey in English or Zulu using a tablet computer (see S3
Survey instrument of S3 Data), had HIV pre-test counselling, physical examination, blood
sample collection, gave swabs for STI testing with a research nurse, and received HIV/STI
post-test counselling and STI treatment. Participants were given direct referrals for HIV
related care or Pre Exposure Prophylaxis (PrEP) access depending on HIV test outcome, and
referrals for syndromic STI treatment onsite or at a local government clinic for partners.
HIV testing and care cascade indicators. Participants gave a blood sample for HIV
rapid-testing, ELISA-confirmed if positive (Alere Combo and Advanced Quality HIV tests,
back-up Alere Determine), CD4 count and viral load-testing (GeneXpert) if HIV-positive. We
considered individuals as virally suppressed if they had <50 viral copies/ml plasma, in line
with current South African treatment guidelines[29]. There is also evidence that individuals
with viral loads greater than 50 copies/ml plasma but less than 1000 copies/ml show increased
likelihood of poor treatment outcomes compared to those with viral load measures less than
50 copies/ml[30]. To aid comparison with past studies and those from other settings, we also
show the proportion virally suppressed according to cut-offs of<200 copies/ml, <400 copies/
ml and<1000 copies/ml in S2 Viral suppression according to different viral load cut-offs of S2
Data.
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Participants were considered aware of their HIV-positive status if they reported in the self-
administered survey ever having tested for HIV and receiving a positive result at their most
recent HIV test. Participants reported month and year of most recent HIV test. Assuming tests
were conducted on the first of each month, together with interview date we created binary
indicators for having tested in the previous three, six and twelve months. Individuals reporting
that they had previously tested HIV-positive were asked if they had received care, whether they
had “ever started taking ART” and whether they were “currently taking ART”.
Other indicators. Participants reported their age in years, previous month’s income,
highest educational attainment, employment status, religion, population group (using South
African categories), marital status, spouse’s gender, neighbourhood of residence and place of
birth, their sexual identity, their sex assigned at birth and their current gender identity. We
considered participants ‘cisgender male’ if both sex assigned at birth and current gender were
male; ‘transfeminine’ if sex assigned at birth was male and current identity was female or trans-
gender, ‘transmasculine’ if sex assigned at birth was female and current identity was male/
transgender and ‘non-binary’ if this was their current gender identity. We used the AUDIT
scale[31] to assess alcohol use and asked about frequency of use of a variety of recreational
drugs, reporting here on use at least once in the past month, excepting tobacco. We used the
PHQ-9 scale to assess depressive symptomatology, with cut-off points at 0, 5, 10, 15 and 20 for
none, mild, moderate and moderately severe and severe depression, and asked participants
whether they openly talked, tried ‘very hard’ or ‘somewhat hard’ to hide that that they had sex
with men with their friends, family and healthcare workers, or neither spoke openly nor tried
to hide it. Participants reported aspects of their sexual behaviour in the previous 3 months sep-
arately for male and female partners (if applicable), including number of partners, sexual roles
(insertive/receptive anal sex or no anal sex, oral sex with men, and vaginal or anal sex with
women), frequency of condom use by role (‘always’, ‘most of the time’, ‘some of the time’,
‘rarely’, ‘never’, made binary always/not always), and whether they had given, or had been
given money, gifts or favours for sex in the previous 12 months. Participants self-reported
experiencing STI symptoms at the time of survey and in the previous 12 months (urethral,
genito-urinary or rectal).
For AUDIT and PHQ-9, if participants were missing just one or two responses to the scale
of questions, we replaced those missing with the mean of the individual’s other responses
(mean of questions 1–9 for PHQ9[32] and questions 2–8 or 9–10 for AUDIT).
RDS recruitment diagnostics. As recommended, recruitment was monitored biweekly
and assessed against RDS assumptions[33]. We describe RDS recruitment in detail in S1
Respondent Driven Sampling recruitment diagnostics of S1 Data. Convergence of HIV status,
viral suppression and HIV testing in the last 6 months were judged as reasonable when the
cumulative RDS-weighted estimate stabilised prior to the full recruitment amongst HIV-posi-
tive and negative participants respectively, examined visually.
Statistical analysis
RDS-II weighting[34] was used to account for sampling design, dropping seed participants
(who were purposively selected), and weighting by inverse MSM network size, assuming this
was proportional to the probability that they would be given a coupon to participate in the
study. Confidence intervals were obtained via bootstrapping.
We described the sociodemographic characteristics of MSM/TG by HIV status, as tested in
the study. We examined reported HIV testing behaviour among participants testing HIV-neg-
ative in the study, and the care cascade amongst those HIV-positive. We described the propor-
tion of HIV-negative MSM/TG who had ever tested, tested in the last three, six and twelve
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months, the location of and satisfaction with most recent test, and future testing preferences.
We examined the associations between these preferences and age, sexual identity and gender
identity characteristics using chi-squared tests with a correction for survey data[35]. As the
outcome was prevalent, we used RDS-II weighted robust Poisson regression (also dropping
seed participants) to obtain weighted prevalence ratios[36, 37] to assess associations between
testing in the last 6 months and sociodemographic, sexual behaviour and self-reported STI
symptoms, examining first bivariate associations and then adjusting sexual behaviour and STI
symptom models for any sociodemographic variables showing evidence for associations with
the outcome (Wald test p<0.2).
The HIV care cascade was constructed by using the RDS-II weighted percentage of all
MSM/TG testing HIV-positive in the study who knew their status, were on ART and whose
viral load was suppressed, and assessing these against the 90-90-90 targets[11]. We described
the proportion of HIV-positive MSM/TG who were ‘satisfied’/ ‘very satisfied’ with the privacy
and respect they were accorded in their most recent HIV care interaction.
Associations with viral suppression among HIV-positive MSM/TG were also examined
using RDS-II weighted robust Poisson regression, as above, first examining sociodemographic
characteristics, recreational drug use, depression, disclosure and sexual behaviours adjusted
only for age, and then retaining in the adjusted model those characteristics for which the Wald
test p value was <0.2.
Analyses were conducted using the RDS: Respondent-Driven Sampling package version
0.9–2[38] and the survey: analysis of complex survey samples package version 3.33–2[39] for R
version 3.5.1[40] and Stata version 12[41].
Ethics statement
This study was approved by the ethics committees at the University of the Witwatersrand, and
the London School of Hygiene and Tropical Medicine.
Results
Sociodemographic characteristics of HIV-positive and HIV-negative MSM/
TG
118/300 (37.5%) MSM/TG were HIV-positive and 182/300 were HIV-negative. One seed par-
ticipant refused HIV testing. Mean age was 26 years, though HIV-positive MSM/TG were
older on average than those HIV-negative, Table 1. The majority were born in Johannesburg,
had completed secondary education, were Black African, unemployed, Christian and unmar-
ried. While most MSM/TG identified as cisgender male, a substantial minority were transfemi-
nine (15.7% among those HIV-positive and 11.7% among those HIV-negative). HIV-negative
MSM/TG more often identified as bisexual, heterosexual or other compared to HIV-positive
MSM/TG (40.5% compared to 11.9%).
HIV testing behaviours and preferences amongst HIV-negative MSM/TG
24/171 HIV-negative participants reported previous HIV testing but had a missing or partially
completed month and year of last HIV test. We did not find statistical evidence for systematic
differences between those with and without last HIV test dates (chi-squared tests p>0.1 for all
characteristics shown in Table 2 and social network size, with the exception of paying a man in
money, gifts or favours in exchange for sex in the last 12 months (‘buying sex’)). Participants
reporting buying sex were more likely to have missing dates for last HIV test, 6/17 compared
to 18/153, p = 0.008.
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Table 1. Sociodemographic characteristics of MSM/TG in Johannesburg by HIV status.
Sociodemographic Characteristics HIV-positive, n = 118 HIV-negative, n = 182
n RDS% n RDS%
Age in years 18–21 15 12.8 59 30.6
20–24 16 13.4 51 30.0
25–29 36 27.6 36 19.7
30+ 51 46.2 36 19.4
Place of birth Born in Johannesburg 76 66.9 105 59.0
Born in South Africa, but not Johannesburg 33 26.6 65 34.6
Born outside of South Africa 7 6.6 11 6.4
Missing 2 1
Neighbourhood residence Soweto 66 58.3 92 53.6
Braamfontein 9 7.0 18 7.7
Hillbrow 16 15.6 28 17.1
Orange Farm 7 5.4 6 3.1
Other 20 13.7 38 18.6
Religion Christianity 104 83.8 155 83.7
Islam 3 2.4 1 1.0
None 9 13.8 26 15.3
Other 1 0.0 0 0.0
Missing 0 1
Education completed Higher Education 34 31.2 41 18.2
High School 70 57.4 129 75.6
Junior High 12 9.7 10 5.7
Primary 1 1.7 1 0.3
None 0 0.0 1 0.3
Missing 1 0
Employment status Employed full-time 16 13.3 16 6.1
Employed part-time 13 12.5 29 16.5
Self employed 14 9.2 19 10.0
Student 3 2.3 16 7.1
Unemployed 69 60.1 98 5.9
Other 2 2.6 4 1.4
Missing 0 1
Income per month / ZAR Under 500 33 28.6 49 27.8
500–999 10 11.1 29 21.6
1000–1999 22 14.5 35 22.5
2000–4999 32 27.3 41 22.6
5000+ 16 18.6 14 5.5
Missing 5 14
Population group Black African 113 96.4 173 94.1
Coloured 4 1.9 5 3.4
White 0 0.0 2 0.5
Prefer not to say 0 0.0 1 1.0
Other 1 1.7 1 1.0
Sexual Identity Gay or homosexual 103 88.1 112 59.6
Bisexual 12 11.7 59 35.3
Heterosexual 0 0.0 3 1.3
Other/Don’t know 1 0.2 8 3.9
(Continued)
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Few HIV-negative MSM/TG reported never previously HIV testing (10/181, 5.5%), while
100/157, 61.5%, reported having tested in the previous 6 months and 118/157, 73.0% tested in
the last 12 months, Table 3.
The most common location for last HIV test was a public clinic or hospital (69/166, 47.1%),
followed by a community HIV testing centre for the general public (41/166, 24.8%), while 25/
166 (13.2%) had most recently tested at an MSM-specific service. Across all HIV testing loca-
tions, MSM/TG reported high levels of satisfaction with the privacy and respect they were
shown. The distribution of preferences for future testing venues was diverse and similar to that
of last testing location, except for a higher preference for an MSM-specific community testing
facility and a private clinic or doctor compared with the percentage who had actually tested in
one (19.8% compared to 13.2%, and 18.3% compared to 9.7% respectively). Just under half of
participants preferred to test in a public clinic or hospital (46.9%) and preferred to have the
test conducted by a doctor/clinician (42.0%), while very few expressed a preference for self-
testing (6.0%).
There was little statistical evidence that testing preferences varied by sociodemographic
characteristics (full results not shown), with the exception of gender identity (p = 0.006). More
transfeminine individuals preferred to test in a public clinic/hospital (18/29, 69.3%) compared
to cisgender (62/142, 50.3%) and non-binary (5/18, 22.9%) MSM/TG, while fewer preferred to
test at a private clinic (2/29, 10.2%) compared to cisgender (28/142, 19.0%) or non-binary indi-
viduals (4/18, 30.5%). There was little difference in the percentages preferring to test in clinics
targeted towards MSM by gender identity, though there was no response option given for
transgender-tailored clinics.
Associations with having HIV tested in the previous 6 months among HIV-
negative MSM/TG
There was little evidence for associations between sociodemographic characteristics and hav-
ing HIV tested in the previous 6 months among HIV-negative MSM/TG. Compared to HIV-
negative cisgender males, transfeminine individuals were 0.57 times as likely to have tested for
HIV in the previous 6 months (95% CI 0.30–1.09), but the statistical evidence for an associa-
tion between testing and gender identity was not significant overall (p = 0.222).
There was strong evidence that MSM/TG who had exchanged sex for money, gifts or
favours in the previous 12 months, ‘sold sex’, were more likely to have HIV tested in the last 6
months (PR = 1.67, 95% CI 1.36–2.05). There was weak statistical evidence that MSM/TG who
Table 1. (Continued)
Sociodemographic Characteristics HIV-positive, n = 118 HIV-negative, n = 182
n RDS% n RDS%
Missing 2 0
Gender identity Cisgender male 95 80.6 138 76.9
Transfeminine 20 15.7 24 11.7
Transmasculine 1 0.3 1 0.3
Non-binary 2 3.4 19 11.2
Marital Status Not married 103 88.2 163 88.4
Married to a man or transgender individual 13 11.8 17 10.6
Married to a woman 0 0.0 2 1.0
Missing 2 0
n = 1 individual did not consent to HIV testing.
https://doi.org/10.1371/journal.pone.0234384.t001
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Table 2. Associations with testing for HIV in the previous 6 months among MSM/TG testing HIV-negative in the study.
Characteristics of the HIV-negative MSM/TG population n RDS% Crude PR 95% CI p value
Sociodemographic Characteristics
Age in years mean not tested / tested 24.5 24.3 1.00 0.97 1.02 0.795
Born in Johannesburg Born in Johannesburg 55/93 58.9 1.00 0.573
Born in SA, not Johannesburg 37/53 69.1 1.17 0.87 1.58
Born outside of SA 8/10 61.6 1.05 0.54 2.01
Religion None 12/24 61.0 1.00 0.965
Christianity/Islam/Other 88/133 61.6 1.01 0.68 1.50
Education completed Junior High School 6/10 65.0 1.06 0.61 1.87 0.973
High School 70/111 61.0 1.00
College/University/Higher Education 24/36 61.3 1.02 0.71 1.46
Employment status Unemployed 59/88 65.3 1.00 0.325
Employed or student 41/69 55.8 0.85 0.63 1.17
Income in the last month 0–499 26/41 55.8 1.00 0.596
(ZAR) 500–999 13/21 68.8 1.23 0.78 1.94
1000–1999 19/31 51.4 0.92 0.55 1.56
2000–4999 27/37 65.9 1.18 0.77 1.82
5000+ 4/14 41.3 0.74 0.32 1.71
Sexual Identity Bisexual, heterosexual, other 36/65 60.8 1.00 0.846
Gay or homosexual 64/92 62.0 0.97 0.72 1.31
Gender identity Cisgender male 81/120 64.4 1.00 0.222
Transfeminine 9/19 36.9 0.57 0.30 1.09
Transmasculine 0/1 0.0 - - -
Non-binary 10/17 67.1 1.04 0.68 1.59
Marital Status Single/divorced/widowed 90/141 60.0 1.00 0.274
Married to a man or transgender individual 8/12 74.0 1.23 0.85 1.80
Married to a woman 2/2 100.0 - - -
Neighbourhood Soweto 51/83 63.1 1.00 0.524
Hillbrow 15/19 74.6 1.18 0.81 1.72
Braamfontein 14/18 66.9 1.06 0.65 1.73
Orange Farm 4/5 65.1 1.03 0.45 2.35
Other� 16/32 44.7 0.71 0.43 1.17
Sexual behaviours
Sex with a man (3months) No 19/41 47.0 1.00 0.083
Yes 81/116 67.6 1.44 0.96 2.16
Sex with a woman (3 months) No 61/94 56.5 1.00 0.239
Yes 39/63 67.3 1.19 0.89 1.59
2+ male partners (3 months) No 83/131 63.0 1.00 0.433
Yes 17/26 51.4 0.82 0.49 1.35
Sell sex to men (12 months) No 78/129 55.1 1.00 <0.001
Yes 22/27 92.0 1.67 1.36 2.05
Buy sex from a man (12 months) No 91/144 61.1 1.00 0.313
Yes 8/11 76.1 1.25 0.81 1.91
Condomless Anal Intercourse with a man (3 months) No 61/104 58.8 1.00 0.383
Yes 39/53 67.1 1.14 0.85 1.54
(Continued)
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had had sex with a man in the previous 3 months were more likely to have tested in the last 6
months compared to those who had not (PR = 1.44, 95% CI 0.96–2.16), and that those who
reported experiencing STI symptoms in the past year were less likely to have tested for HIV in
the previous 6 months, (PR = 0.67, 95% CI 0.42–1.07).
Viral suppression and engagement in treatment and care among HIV-
positive MSM/TG
The percentage of HIV-positive MSM/TG who were virally suppressed (<50 copies/ml) was
estimated to be 46.9% (95% CI 31.5–62.3%, n = 58/118), Fig 1, Table 4. Self-reported knowl-
edge of HIV-positive status was estimated to be 56.5% (95% CI 40.4–72.6%, n = 76/118) and
current ART coverage 30.0% (95% CI 17.1–43.0%, n = 39/118) of all those HIV-positive. Of
those who reported currently taking ART, there were 10/39 who were not virally suppressed.
There were 29 participants who tested positive for HIV and were virally suppressed but who
either did not self-report ever testing positive for HIV, or did not self-report current ART use.
Among HIV-positive MSM/TG, 75.6% had last attended HIV care at public clinics and
18.1% at MSM-specific clinics, with the remaining at private clinics. There were 89.3%
(n = 63/90) who were satisfied with their last clinic’s privacy and 91.5% (n = 65/70) who were
satisfied with the respect they were shown; these figures were 100% among those visiting
MSM-specific clinics.
Factors associated with viral suppression amongst HIV-positive MSM/TG
Being virally suppressed was associated in crude analyses with increasing age, PR = 1.03 for
each year, 95% CI 0.99–1.06, Table 5. HIV-positive MSM/TG living in Braamfontein, a central
neighbourhood, as compared to Soweto, were less likely to be virally suppressed, though the
numbers were small (1/9 compared to 39/66, PR = 0.04, 95% CI 0.00–0.33). MSM/TG who
were not open with their family about the fact that they had sex with men were less likely to be
virally suppressed, though the evidence for the association was weak (PR = 0.72, 95% CI 0.46–
1.14). There was evidence that MSM/TG reporting recreational drug use in the last month
were more likely to be virally suppressed (PR = 1.56, 95% CI 1.00–2.44). Having paid a man in
money, gifts or favours in exchange for sex in the past 12 months was strongly associated with
being virally suppressed compared to not buying sex in the last 12 months (PR = 2.16, 95%
1.61–2.89).
Table 2. (Continued)
Characteristics of the HIV-negative MSM/TG population n RDS% Crude PR 95% CI p value
Sexual role with men during anal sex, (3 months) No anal sex with men 23/45 53.0 0.68 0.45 1.03 0.262
Receptive anal intercourse 27/39 56.4 0.73 0.47 1.13
Insertive anal intercourse 35/53 67.2 0.86 0.61 1.22
Versatile 15/20 77.8 1.00
Self-reported STI symptoms (12 months) No 82/123 66.2 1.00 0.094
Yes 18/34 44.5 0.67 0.42 1.07
n = 157 HIV-negative with responses to ever tested and date of last test.
n’s do not add to total where there are some missing responses.
All models exclude seed participants and include weighting for inverse network size (RDS-II).
There was not evidence for associations (Wald test p<0.2) between sociodemographic characteristics and testing, so we show only univariate associations.
�Other neighbourhoods include those within Johannesburg with fewer than 10 participants in the study sample.
https://doi.org/10.1371/journal.pone.0234384.t002
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In adjusted analyses, the evidence that older MSM/TG were more likely to be virally sup-
pressed remained (aPR = 1.03, 96% CI 1.00–1.06), while the statistical evidence for neighbour-
hood associations weakened somewhat (p = 0.070). The association between viral suppression
and recreational drug use also weakened (aPR = 1.36, 95% CI 0.89–2.06, p = 0.155). Strong evi-
dence that MSM who had bought sex were more likely to virally suppressed remained, though
the strength of the association reduced somewhat (aPR = 1.53, 95% CI 1.12–2.08).
Discussion
We estimated a very high HIV prevalence among MSM/TG in Johannesburg, and found half
of those HIV-positive to be virally unsuppressed. These findings indicate gaps in the HIV care
cascade that represent missed opportunities to improve the health of HIV-positive MSM/TG
and to prevent ongoing HIV transmission. Younger MSM/TG who were HIV-positive were
Table 3. HIV testing history and experiences amongst MSM/TG testing HIV-negative in the study.
Among all testing HIV-negative, n = 182
Testing history n/N RDS %
Ever had an HIV test 171/181 94.5
Had an HIV test in the previous 12 months 118/157� 73.0
Had an HIV test in the past 6 months 100/157� 61.5
Had an HIV test in the past 3 months 77/157� 49.8
’Satisfied’ or ’Very
satisfied’ with
privacy
’Satisfied’ or ’Very
satisfied’ with
respect shown
Testing preferences n/N RDS % n RDS % n RDS %
Where last tested for HIV, of those ever testing��
Public hospital or clinic 69/167 47.1 68 97.7 66 98.7
Private hospital or clinic 20/167 9.7 19 98.1 19 98.1
Community HIV testing service for the public 41/167 24.9 37 92.7 40 99.1
Community HIV testing service for MSM only 25/167 13.2 24 95.8 24 95.8
At home 3/167 2.4 3 100 3 100
University/school (write-in response) 7/167 2.4 7 100 7 100
Research study (write-in response) 2/167 0.4 2 100 2 100
Amongst those HIV negative and reporting that their last test was negative, n = 163���:
Where would you choose to test in future?
Public hospital or clinic 69/162 46.9
Private hospital or clinic 27/162 18.3
Community HIV testing service for the public 17/162 8.8
Community HIV testing service for MSM only 39/162 19.8
At home 10/162 6.2
Who would you prefer to perform an HIV test in future?
Doctor or clinical officer 62/162 42.1
Nurse 27/162 17.0
Counsellor 19/162 12.4
MSM community worker 44/162 22.6
Me (i.e., self-test) 10/162 6.0
�n = 24 responses to last HIV test date were missing, n = 1 missing ever tested response.
��n = 5 responses to where last tested were missing.
���n = 1 response to where would like to test in future missing.
https://doi.org/10.1371/journal.pone.0234384.t003
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less likely to be virally suppressed, emphasising the need for regular and accessible testing and
support to engage in HIV care for this group.
We found a higher proportion of MSM/TG to be virally suppressed at 47% (32–62%) than
the 34% estimated among all adult males living with HIV in Gauteng in 2017 [12], the 26%
estimated in Johannesburg in 2016 [13] and similar to the 47% (95% CI 43–52%) estimated to
be virally suppressed among the HIV-positive adult population in South Africa as a whole in
2017[42]. This was the case even with our lower viral load cut-off of 50 copies/ml plasma as
compared to 400/ml plasma. Our estimate is also higher than modelled estimates for virologi-
cal suppression among South African MSM (22%, data from 2013–2015)[43]. It is plausible
that in addition to challenges related to having sex with men, HIV-positive MSM/TG experi-
ence some of the same barriers to achieving viral suppression that men as whole do, as esti-
mates for viral suppression among women are higher than those of men overall (43%
compared to 58% nationally among adults[42]). Knowledge of status and current ART use
among HIV-positive MSM/TG were much higher than that reported amongst MSM in two
districts of neighbouring Mpumalanga province in 2012–2013, (56.5% compared to 28.1% and
Fig 1. The HIV care cascade among MSM/TG in Johannesburg, n = 300.
https://doi.org/10.1371/journal.pone.0234384.g001
Table 4. The HIV care cascade among MSM/TG in Johannesburg, n = 300.
n Unweighted sample % RDS-II weighted % 95% CI
Of All HIV-Positive, n = 118
Knows HIV-Positive Status no 42
yes 76 64.4 56.5 40.4, 72.6
Currently on ART of all HIV-Positive no 79
yes 39 33.1 30.0 17.1, 43.0
Virally suppressed of all HIV-positive no: 50+ copies/ml 60
yes: <50 copies/ml 58 49.2 46.9 31.5, 62.3
Expressed as 90-90-90
Knows HIV-Positive Status no 42
yes 76 64.4 56.5 40.4, 72.6
Currently on ART of those who know they are positive no 37
yes 39 51.3 53.2 32.7, 73.7
Virally suppressed of those on ART no: 50+ copies/ml 10
yes: <50 copies/ml 29 74.4 77.3 51.4, 100.0
https://doi.org/10.1371/journal.pone.0234384.t004
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Table 5. Associations with viral suppression among HIV-positive MSM/TG.
Characteristics of the HIV-positive MSM/TG population n RDS% Crude
PR
95% CI p value �aPR 95% CI p
value
Sociodemographic characteristics, sexual and gender identity
Age in years Mean unsuppressed / suppressed 28.1 30.2 1.03 0.99 1.06 0.130 1.03 1.00 1.06 0.051
Income per month / ZAR Under 500 17/33 42.5 1.00 0.869
500–999 6/10 48.9 1.15 0.48 2.73
1000–1999 10/22 41.0 0.96 0.43 2.14
2000–4999 17/32 56.8 1.34 0.72 2.47
5000+ 7/16 51.2 1.20 0.58 2.51
Born in Johannesburg Born in Johannesburg 43/76 47.6 1.00 0.631
Born in SA, not Johannesburg 12/33 43.8 0.92 0.53 1.61
Born outside of SA 3/7 65.2 1.37 0.66 2.87
Religion None 3/10 24.3 1.00 0.226
Christianity/Islam/Other 55/
108
50.7 2.09 0.64 6.81
Education completed Up to Junior High School 8/13 50.0 1.07 0.52 2.20 0.985
High School 32/70 46.9 1.00
College/University/HE 18/34 47.0 1.00 0.59 1.71
Employment status Unemployed 33/69 46.0 1.00 0.768
Employed full-time, part-time, student 25/48 49.4 1.07 0.67 1.72
Sexual Identity Gay or homosexual 50/
103
52.0 1.00 0.738
Bisexual, heterosexual or other 7/13 46.3 1.12 0.57 2.20
Gender Identity Cisgender male 47/95 48.8 1.00 0.477
Transfeminine 10/20 46.1 0.94 0.52 1.72
Transmasculine 1/1 100.0 2.05 1.58 2.64
Non-binary 0/2 0.0
Marital Status Single/divorced/widowed 50/
103
45.8 1.00 0.515
Married/civil union/legal to a man or
transgender individual
7/13 56.8 1.24 0.65 2.35
Married to a woman 0/0 0 - - -
Neighbourhood Soweto 39/66 55.8 1.00 0.032 1.00 0.070
Hillbrow 6/16 43.2 0.77 0.38 1.58 0.67 0.32 1.39
Braamfontein 1/9 2.2 0.04 0.00 0.33 0.05 0.01 0.48
Orange Farm 5/7 58.2 1.04 0.44 2.46 0.90 0.47 1.71
Other 7/20 31.5 0.56 0.26 1.22 0.62 0.29 1.32
Mental health, alcohol and substance use, disclosure of sexuality
PHQ9 None 29/57 47.4 1.00 0.924
Mild depression 10/29 39.1 0.82 0.42 1.61
Moderate depression 11/18 56.7 1.20 0.65 2.20
Moderately severe or severe depression 4/8 56.4 1.02 0.38 2.75
Missing >2 responses to scale questions 4/6 45.1 0.95 0.33 2.71
AUDIT Low risk drinking 28/53 50.2 1.00 0.632
In excess of low risk drinking guidelines 19/41 44.7 0.89 0.52 1.54
Harmful or hazardous drinking 4/10 36.0 0.72 0.24 2.11
Alcohol dependence 3/8 24.3 0.48 0.15 1.60
Missing >2 responses to scale questions 4/6 64.3 1.28 0.62 2.65
(Continued)
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14.1% aware of status, 30% versus 14% and 10% on ART)[44]. Our higher estimates could be
related to having an urban sample of MSM/TG and to our more recent data collection. None-
theless, the percentage of HIV-positive MSM/TG whom we found to be virally suppressed
remains well below the UNAIDS target of 73% of all those HIV-positive, indicating gaps in the
HIV care cascade. It is encouraging however that HIV-positive MSM/TG receiving HIV care,
76% of whom were attending public clinics and hospitals, reported high levels of satisfaction
with the service they received.
We found that HIV-positive MSM/TG who had bought sex from a man in the past 12
months were more likely to be virally suppressed. Our findings could possibly reflect a higher
recognition of risk and thus increased care engagement among those buying sex, but we are
not able to determine causality. Studies among other MSM/TG populations have found that
substance use, alcohol use and mental health are associated with worse care cascade outcomes
[45], and the fact that we did not find statistically significant associations with these
Table 5. (Continued)
Characteristics of the HIV-positive MSM/TG population n RDS% Crude
PR
95% CI p value �aPR 95% CI p
value
Use of at least one substance in last month No 37/81 39.9 1.00 0.052 1.00 0.155
Yes 21/37 62.4 1.56 1.00 2.44 1.36 0.89 2.06
Openly talk about having sex with men with
friends
Yes 38/77 50.5 1.00 0.429
No 19/40 41.0 0.81 0.48 1.36
Openly talk about having sex with men with
family
Yes 26/43 58.5 1.00 0.169 1.00 0.203
No 30/72 42.4 0.72 0.46 1.14 0.75 0.49 1.16
Openly talk about having sex with men with
healthcare workers
Yes 39/77 45.2 1.00 0.704
No 18/40 49.6 1.10 0.68 1.79
Sexual Behaviours
Sex with a man (3months) No 5/22 23.8 1.00 0.119 1.00 0.203
Yes 53/96 52.4 2.20 0.82 5.86 1.53 0.61 3.86
Sex with a woman (3 months) No 53/
107
47.1 1.00 0.941
Yes 5/11 45.7 0.97 0.44 2.14
2+ male partners (3 months) No 37/78 47.3 1.00 0.910
Yes 23/40 45.9 0.97 0.59 1.61
Sell sex to men (12 months) No 37/78 46.8 1.00 0.860
Yes 20/37 48.9 1.05 0.63 1.73
Buy sex from a man (12 months) No 47/
102
43.0 1.00 <0.001 1.00 0.008
Yes 11/14 92.8 2.16 1.61 2.89 1.53 1.12 2.08
Condomless Anal Intercourse with a man (3
months)
No 35/68 51.2 1.00 0.350
Yes 23/50 40.3 0.79 0.48 1.30
Sexual role with men during anal sex, (3
months)
No anal sex with men last 3 months 5/23 22.8 0.36 0.13 1.01 0.239
Receptive anal intercourse 26/46 45.7 0.72 0.42 1.24
Insertive anal intercourse 11/20 53.0 0.84 0.46 1.54
Versatile 13/23 63.2 1.00
All models exclude seed participants and include weighting for inverse network size (RDS-II).
Adjusted models were adjusted for age and those variables found to be p value <0.2 in the crude analysis. p values are from Wald tests.
n’s do not add to total where there are some missing responses.
�Other neighbourhoods include those within Johannesburg with fewer than 10 participants in the study sample.
https://doi.org/10.1371/journal.pone.0234384.t005
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characteristics should be treated with caution. Our sub-sample was small, statistical error
remains a possibility and we have not disaggregated different types of drug use.
Almost two thirds of HIV-negative MSM/TG reported having HIV tested within the previ-
ous 6 months, higher than among MSM in Soweto in 2008 (28%)[24, 25] and MSM in Mpu-
malanga in 2014–2015 prior to a testing intervention (38%)[46]. Encouragingly, testing was
associated with some indicators of higher risk, including selling sex to men, though not self-
reported STI symptoms. There remains a need for sustained HIV/STI testing messages. Trans-
feminine individuals were less likely than cisgender male individuals to have HIV tested, simi-
lar to findings from Cape Town[47], though the statistical evidence for an association between
testing and gender identity was weak; further investigation is needed. Of MSM/TG who did
attend HIV testing, it is encouraging that high levels of privacy and respect at last testing expe-
rience were reported. That there was not a clear majority preference for testing location and
person performing the tests underscores the need for a high volume and variety of accessible
and acceptable services for a diverse MSM/TG population. While few MSM/TG reported a
preference for HIV self-testing in our study, it is possible that this stems from unfamiliarity: a
recent study of MSM in Mpumalanga found high levels of satisfaction with HIV self-testing
and increased testing frequency amongst those who had tried it[46], though studies from else-
where have also found that men are reluctant to receive a diagnosis on their own[48].
Limitations
Our study set out to obtain population-representative estimate of HIV testing and the care cas-
cade among MSM/TG in Johannesburg, rather than relying upon modelled estimates. While
we found that study outcomes of HIV status, viral load and testing and many sociodemo-
graphic characteristics showed evidence of converging well, there were some challenges in
achieving a representative sample of MSM/TG (S1 Data), as in other MSM surveys from the
continent[49, 50]. Compared to another study of MSM in Soweto from 2008, we found a
lower proportion of MSM/TG who identified as heterosexual or ‘straight’[25], and our esti-
mates of sexual identity had not converged, S1 Fig A2e of S1 Data, likely indicating a difficulty
in sampling this group. A higher proportion of participants described themselves as Black Afri-
can compared to the population of Johannesburg overall; recruitment chains originating from
White seeds did not achieve more than two sample waves and White and Asian individuals
were not recruited by others. Most participants were recruited from four of the nine seeds.
Following stratification by HIV status, we might have had limited power for investigating
factors that are associated with viral suppression among HIV-positive MSM/TG or recent HIV
testing among HIV-Negative MSM/TG.
A further limitation was our reliance upon self-reported measures of HIV testing/status
awareness and ART use. That half of MSM/TG verified to be virally suppressed did not report
currently taking ART and/or did not report being aware of their status suggests that diagnosis
and current ART use were under-reported among men testing HIV-positive in our study, dis-
crepancies that we are investigating further[51]. Other surveys and studies using self-reported
care cascade indicators have also pointed out this problem[52–56], with social desirability
biases and survey misunderstandings posited as possible explanations. Confusion from care
interactions have also been reported in South Africa[57]. Misinterpretations about the distinc-
tion between ‘undetectable’ viral load and ‘negative’ HIV status in provider interactions may
represent an increasingly importance source of misclassification that should be investigated
further. While our estimate of viral suppression is biologically ascertained, these reporting
biases limit our ability to guide programming in identifying whether the gaps in diagnosis ver-
sus initiation and retention on ART are most significant.
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Conclusions
It is encouraging that MSM/TG do not appear to be lagging in the HIV care cascade compared
to the general male population in Johannesburg and are reporting positive care experiences.
However, given their higher risks as a group and very high HIV burden, there is a need to con-
tinue to focus resources towards further improvement, particularly among younger MSM/TG.
A better understanding of sexual mixing and transmission patterns could aid in targeting,
development of a differentiated care approach to serve the diversity of MSM would be appro-
priate, and a dedicated study to understand the needs of the transgender population is
warranted.
Supporting information
S1 Data. Respondent driven sampling recruitment diagnostics.
(DOCX)
S2 Data. Viral suppression according to different viral load cut-offs.
(DOCX)
S3 Data. Survey instrument.
(PDF)
Acknowledgments
We thank and acknowledge the participants of the TRANSFORM study, and are grateful to
assistance from the ANOVA Health Institute, Ten81 and SOHACA.
Membership of the TRANSFORM Study Group includes: Thesla Palanee-Phillips�1, Joshua
Kimani2,3, Peter Weatherburn4, Adam Bourne5, Adrian D Smith6, Elizabeth Fearon7, Will
Nutland4, Siyanda Tenza1, Rhoda Kabuti3, Kerushini Moodley1, Cecilia Mokoena1, Jennifer
Liku3, Anthony Tukai3, Hellen Babu3, Amos Mugambi3, Chrispo Nyamweya3, Mary Kung’u3,
Polly Ngurukiri3, Peter Muthoga3, Erastus Irungu3
1. Wits Reproductive Health and HIV Institute, Johannesburg, South Africa
2. Department of Community Health Sciences, University of Manitoba, Winnipeg, Canada
3. Partners for Health and Development in Africa, Nairobi, Kenya
4. Department of Public Health, Environments and Society, London School of Hygiene and
Tropical Medicine, London, United Kingdom
5. Australian Research Centre in Sex, Health and Society, LaTrobe University, Melbourne,
Australia
6. Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom
7. Department of Global Health and Development, London School of Hygiene and Tropical
Medicine, London, United Kingdom
�Principal Investigator: tpalanee@wrhi.ac.za
Author Contributions
Conceptualization: Elizabeth Fearon, Adrian D. Smith, Adam Bourne, Peter Weatherburn,
Thesla Palanee-Phillips.
Data curation: Elizabeth Fearon, Siyanda Tenza, Cecilia Mokoena, Kerushini Moodley.
PLOS ONE HIV testing and care among MSM and transgender individuals in Johannesburg
PLOS ONE | https://doi.org/10.1371/journal.pone.0234384 June 17, 2020 15 / 19
Formal analysis: Elizabeth Fearon.
Investigation: Adam Bourne, Peter Weatherburn, Thesla Palanee-Phillips.
Methodology: Elizabeth Fearon.
Supervision: Peter Weatherburn, Thesla Palanee-Phillips.
Writing – original draft: Elizabeth Fearon.
Writing – review & editing: Elizabeth Fearon, Siyanda Tenza, Cecilia Mokoena, Kerushini
Moodley, Adrian D. Smith, Adam Bourne, Peter Weatherburn, Thesla Palanee-Phillips.
References
1. Smith AD, Tapsoba P, Peshu N, Sanders EJ, Jaffe HW. Men who have sex with men and HIV/AIDS in
sub-Saharan Africa. Lancet. 2009; 374(9687):416–22. https://doi.org/10.1016/S0140-6736(09)61118-1
PMID: 19616840
2. Beyrer C, Makofane K, Orazulike I, Diouf D, Baral SD. Towards Equity in Service Provision for Gay Men
and Other Men Who Have Sex with Men in Repressive Contexts. PLoS Med. 2016; 13(10):e1002154.
https://doi.org/10.1371/journal.pmed.1002154 PMID: 27780210
3. Beyrer C, Baral SD, Collins C, Richardson ET, Sullivan PS, Sanchez J, et al. The global response to
HIV in men who have sex with men. Lancet. 2016; 388(10040):198–206. https://doi.org/10.1016/
S0140-6736(16)30781-4 PMID: 27411880
4. World Health Organization. Focus on key populations in national HIV strategic plans in the African
Region. Brazzaville: 2018.
5. Let our Actions Count: South Africa’s National Strategic Plan for HIV, TB and STI’s 2017–2022. South
African National AIDS Council. Pretoria, South Africa, 2017.
6. Reniers G, Slaymaker E, Nakiyingi-Miiro J, Nyamukapa C, Crampin AC, Herbst K, et al. Mortality trends
in the era of antiretroviral therapy: evidence from the Network for Analysing Longitudinal Population
based HIV/AIDS data on Africa (ALPHA). AIDS. 2014; 28 Suppl 4:S533–42.
7. Tanser F, Barnighausen T, Grapsa E, Zaidi J, Newell ML. High coverage of ART associated with decline
in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science. 2013; 339(6122):966–71.
https://doi.org/10.1126/science.1228160 PMID: 23430656
8. Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, Degen O, et al. Risk of HIV transmission
through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive
antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lan-
cet. 2019.
9. Solomon SS, Mehta SH, McFall AM, Srikrishnan AK, Saravanan S, Laeyendecker O, et al. Community
viral load, antiretroviral therapy coverage, and HIV incidence in India: a cross-sectional, comparative
study. Lancet HIV. 2016; 3(4):e183–90. https://doi.org/10.1016/S2352-3018(16)00019-9 PMID:
27036994
10. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Antiretroviral
Therapy for the Prevention of HIV-1 Transmission. N Engl J Med. 2016; 375(9):830–9. https://doi.org/
10.1056/NEJMoa1600693 PMID: 27424812
11. UNAIDS. 90-90-90: An ambitious treatment target to help end the AIDS epidemic. Geneva: UNAIDS,
2014.
12. UNAIDS. Fact sheet on HIV among men in South Africa. Pretoria: UNAIDS Country Office South
Africa, 2018.
13. Stuart RM, Fraser-Hurt N, Kerr CC, Mabusela E, Madi V, Mkhwanazi F, et al. The City of Johannesburg
can end AIDS by 2030: modelling the impact of achieving the Fast-Track targets and what it will take to
get there. J Int AIDS Soc. 2018; 21(1).
14. Risher K, Mayer KH, Beyrer C. HIV treatment cascade in MSM, people who inject drugs, and sex work-
ers. Curr Opin HIV AIDS. 2015; 10(6):420–9.
15. Charurat ME, Emmanuel B, Akolo C, Keshinro B, Nowak RG, Kennedy S, et al. Uptake of treatment as
prevention for HIV and continuum of care among HIV-positive men who have sex with men in Nigeria. J
Acquir Immune Defic Syndr. 2015; 68 Suppl 2:S114–23.
16. Hakim AJ, Coy K, Patnaik P, Telly N, Ballo T, Traore B, et al. An urgent need for HIV testing among
men who have sex with men and transgender women in Bamako, Mali: Low awareness of HIV infection
PLOS ONE HIV testing and care among MSM and transgender individuals in Johannesburg
PLOS ONE | https://doi.org/10.1371/journal.pone.0234384 June 17, 2020 16 / 19
and viral suppression among those living with HIV. PLoS One. 2018; 13(11):e0207363. https://doi.org/
10.1371/journal.pone.0207363 PMID: 30419065
17. Hladik W, Sande E, Berry M, Ganafa S, Kiyingi H, Kusiima J, et al. Men Who Have Sex with Men in
Kampala, Uganda: Results from a Bio-Behavioral Respondent Driven Sampling Survey. AIDS Behav.
2017; 21(5):1478–90. https://doi.org/10.1007/s10461-016-1535-2 PMID: 27600752
18. Stannah J, Dale E, Elmes J, Staunton R, Beyrer C, Mitchell KM, et al. HIV testing and engagement with
the HIV treatment cascade among men who have sex with men in Africa: a systematic review and
meta-analysis. Lancet HIV. 2019; 6(11):e769–e87. https://doi.org/10.1016/S2352-3018(19)30239-5
PMID: 31601542
19. Lane T, Mogale T, Struthers H, McIntyre J, Kegeles SM. "They see you as a different thing": the experi-
ences of men who have sex with men with healthcare workers in South African township communities.
Sex Transm Infect. 2008; 84(6):430–3. https://doi.org/10.1136/sti.2008.031567 PMID: 19028941
20. Shaver J, Sullivan P, Siegler A, de Voux A, Phaswana-Mafuya N, Bekker LG, et al. Comparing Provider
and Client Preferences for HIV Prevention Services in South Africa among Men Who Have Sex with
Men. J Int Assoc Provid AIDS Care. 2017; 16(6):562–71. https://doi.org/10.1177/2325957417736611
PMID: 29108450
21. Zahn R, Grosso A, Scheibe A, Bekker LG, Ketende S, Dausab F, et al. Human Rights Violations among
Men Who Have Sex with Men in Southern Africa: Comparisons between Legal Contexts. PLoS One.
2016; 11(1):e0147156. https://doi.org/10.1371/journal.pone.0147156 PMID: 26764467
22. Rees K, Radebe O, Arendse C, Modibedi C, Struthers HE, McIntyre JA, et al. Utilization of Sexually
Transmitted Infection Services at 2 Health Facilities Targeting Men Who Have Sex With Men in South
Africa: A Retrospective Analysis of Operational Data. Sex Transm Dis. 2017; 44(12):768–73. https://
doi.org/10.1097/OLQ.0000000000000679 PMID: 28876299
23. South Africa Demographic and Health Survey 2016: Key Indicators Report. Pretoria, South Africa:
National Department of Health; Statistics South Africa, 2017.
24. Siegler AJ, Sullivan PS, de Voux A, Phaswana-Mafuya N, Bekker LG, Baral SD, et al. Exploring repeat
HIV testing among men who have sex with men in Cape Town and Port Elizabeth, South Africa. AIDS
Care. 2015; 27(2):229–34. https://doi.org/10.1080/09540121.2014.947914 PMID: 25134823
25. Lane T, Raymond HF, Dladla S, Rasethe J, Struthers H, McFarland W, et al. High HIV prevalence
among men who have sex with men in Soweto, South Africa: results from the Soweto Men’s Study.
AIDS Behav. 2011; 15(3):626–34. https://doi.org/10.1007/s10461-009-9598-y PMID: 19662523
26. University of California San Francisco. Report of the South Africa men-who-have-sex-with- men Data
Triangulation Project. San Francisco: 2015.
27. Makusha T, Mabaso M, Richter L, Desmond C, Jooste S, Simbayi L. Trends in HIV testing and associ-
ated factors among men in South Africa: evidence from 2005, 2008 and 2012 national population-based
household surveys. Public Health. 2017; 143:1–7. https://doi.org/10.1016/j.puhe.2016.10.017 PMID:
28159020
28. Sabin KM, Johnston LG. Epidemiological challenges to the assessment of HIV burdens among key pop-
ulations: respondent-driven sampling, time-location sampling and demographic and health surveys.
Curr Opin HIV AIDS. 2014; 9(2):101–6. Epub 2014/01/28. https://doi.org/10.1097/COH.
0000000000000046 PMID: 24464090
29. 2019 ART Clinical Guidelines for the Management of HIV in Adults, Pregnancy, Adolescents, Children,
Infants and Neonates Pretoria, South Africa: Republic of South Africa National Department of Health.
October, 2019.2019.
30. Hermans LE, Moorhouse M, Carmona S, Grobbee DE, Hofstra LM, Richman DD, et al. Effect of HIV-1
low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African
treatment programmes: a multicentre cohort study. Lancet Infect Dis. 2018; 18(2):188–97. https://doi.
org/10.1016/S1473-3099(17)30681-3 PMID: 29158101
31. Babor TF, de la Fuente JR, Saunders J, Grant M. The Alcohol Use Disorders Identification Test. Guide-
lines for use in primary health care. Geneva, Switzerland: World Health Organization, 1992.
32. Kroenke K, Spitzer RL, Williams JB, Lowe B. The Patient Health Questionnaire Somatic, Anxiety, and
Depressive Symptom Scales: a systematic review. Gen Hosp Psychiatry. 2010; 32(4):345–59. https://
doi.org/10.1016/j.genhosppsych.2010.03.006 PMID: 20633738
33. Gile KJ, Johnston LG, Salganik MJ. Diagnostics for Respondent-driven Sampling. J R Stat Soc Ser A
Stat Soc. 2015; 178(1):241–69. https://doi.org/10.1111/rssa.12059 PMID: 27226702
34. Volz E, Heckathorn DD. Probability Based Estimation Theory for Respondent Driven Sampling. Journal
of Official Statistics. 2008; 24(1):79–97.
35. Rao JNK, Scott AJ. On chi-squared tests for multiway contingency tables with cell proportions estimated
from survey data. Annals of Statistics 1984; 12:46–60.
PLOS ONE HIV testing and care among MSM and transgender individuals in Johannesburg
PLOS ONE | https://doi.org/10.1371/journal.pone.0234384 June 17, 2020 17 / 19
36. Chen W, Qian L, Shi J, Franklin M. Comparing performance between log- binomial and robust Poisson
regression models for estimating risk ratios under model misspecification. BMC Medical Research
Methodology. 2018; 18(63).
37. Barros AJD, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical
comparison of models that directly estimate the prevalence ratio. BMC Medical Research Methodology.
2003; 3(21).
38. Handcock MS, Fellows IE, Gile KJ. RDS: Respondent-Driven Sampling. 0.9–2 ed2019.
39. Lumley T. survey: analysis of complex survey samples. 3.33–2 ed2018.
40. R Core Team. R: A language and environment for statistical computing. 3.5.1 ed. Vienna, Austria: R
Foundation for Statistical Computing; 2018.
41. StataCorp. Stata Statistical Software: Release 12. College station, Texas: StataCorp LP; 2011.
42. AIDSinfo. Country factsheets: South Africa 2017. Geneva: UNAIDS, 2018.
43. Scheibe A, Grasso M, Raymond HF, Manyuchi A, Osmand T, Lane T, et al. Modelling the UNAIDS 90-
90-90 treatment cascade for gay, bisexual and other men who have sex with men in South Africa: using
the findings of a data triangulation process to map a way forward. AIDS Behav. 2018; 22(3):853–9.
https://doi.org/10.1007/s10461-017-1773-y PMID: 28444469
44. Lane T, Osmand T, Marr A, Shade SB, Dunkle K, Sandfort T, et al. The Mpumalanga Men’s Study
(MPMS): results of a baseline biological and behavioral HIV surveillance survey in two MSM communi-
ties in South Africa. PLoS One. 2014; 9(11):e111063. https://doi.org/10.1371/journal.pone.0111063
PMID: 25401785
45. Friedman MR, Stall R, Silvestre AJ, Wei C, Shoptaw S, Herrick A, et al. Effects of syndemics on HIV
viral load and medication adherence in the multicentre AIDS cohort study. AIDS. 2015; 29(9):1087–96.
https://doi.org/10.1097/QAD.0000000000000657 PMID: 25870981
46. Lippman SA, Lane T, Rabede O, Gilmore H, Chen YH, Mlotshwa N, et al. High Acceptability and
Increased HIV-Testing Frequency After Introduction of HIV Self-Testing and Network Distribution
Among South African MSM. J Acquir Immune Defic Syndr. 2018; 77(3):279–87. https://doi.org/10.
1097/QAI.0000000000001601 PMID: 29210826
47. Jobson G, Tucker A, de Swardt G, Rebe K, Struthers H, McIntyre J, et al. Gender identity and HIV risk
among men who have sex with men in Cape Town, South Africa. AIDS Care. 2018; 30(11):1421–5.
https://doi.org/10.1080/09540121.2018.1465175 PMID: 29667424
48. Witzel TC, Weatherburn P, Rodger AJ, Bourne AH, Burns FM. Risk, reassurance and routine: a qualita-
tive study of narrative understandings of the potential for HIV self-testing among men who have sex
with men in England. BMC Public Health. 2017; 17(1):491. https://doi.org/10.1186/s12889-017-4370-0
PMID: 28532401
49. Johnson LF, Mulongeni P, Marr A, Lane T. Age bias in survey sampling and implications for estimating
HIV prevalence in men who have sex with men: insights from mathematical modelling. Epidemiol Infect.
2018; 146(8):1036–42. https://doi.org/10.1017/S0950268818000961 PMID: 29708084
50. Cloete A, Simbayi L, Rehle T, Jooste S, Mabaso M, Townsend L, et al. The South African Marang
Men’s Project HIV bio-behavioural surveys conducted among men who have sex with men in Cape
Town, Durban and Johannesburg using respondent-driven sampling. Cape Town: 2014.
51. Fearon E, Nyamweya C, Kabuti R, Kung’u M, Irungu E, Muthoga P, et al. Discrepancies between self-
reported HIV care cascade indicators and viral load measures among HIV-positive MSM/TG in Nairobi
and Johannesburg. University of Nairobi Collaborative meeting on HIV and STDs 2019; Nairobi2019.
52. Das M, Raymond HF, Chu P, Nieves-Rivera I, Pandori M, Louie B, et al. Measuring the unknown: calcu-
lating community viral load among HIV-infected MSM unaware of their HIV status in San Francisco from
National HIV Behavioral Surveillance, 2004–2011. J Acquir Immune Defic Syndr. 2013; 63(2):e84–6.
Epub 2013/05/15. https://doi.org/10.1097/QAI.0b013e31828ed2e4 PMID: 23666144
53. Wafula R, Masyuko S, Ng’ang’a L, Kim AA, Gichangi A, Mukui I, et al. Engagement in HIV care among
Kenyan adults and adolescents: results from a national population-based survey. J Acquir Immune
Defic Syndr. 2014; 66 Suppl 1:S98–105. Epub 2014/04/16.
54. Cowan FM, Davey CB, Fearon E, Mushati P, Dirawo J, Cambiano V, et al. The HIV Care Cascade
Among Female Sex Workers in Zimbabwe: Results of a Population-Based Survey From the Sisters
Antiretroviral Therapy Programme for Prevention of HIV, an Integrated Response (SAPPH-IRe) Trial. J
Acquir Immune Defic Syndr. 2017; 74(4):375–82. https://doi.org/10.1097/QAI.0000000000001255
PMID: 27930599
55. Fogel JM, Sandfort T, Zhang Y, Guo X, Clarke W, Breaud A, et al. Accuracy of Self-Reported HIV Sta-
tus Among African Men and Transgender Women Who Have Sex with Men Who were Screened for
Participation in a Research Study: HPTN 075. AIDS Behav. 2018.
PLOS ONE HIV testing and care among MSM and transgender individuals in Johannesburg
PLOS ONE | https://doi.org/10.1371/journal.pone.0234384 June 17, 2020 18 / 19
56. Hoots BE, Wejnert C, Martin A, Haaland R, Masciotra S, Sionean C, et al. Undisclosed HIV infection
among MSM in a behavioral surveillance study. AIDS. 2019; 33(5):913–8. https://doi.org/10.1097/QAD.
0000000000002147 PMID: 30649053
57. Mooney AC, Campbell CK, Ratlhagana MJ, Grignon JS, Mazibuko S, Agnew E, et al. Beyond Social
Desirability Bias: Investigating Inconsistencies in Self-Reported HIV Testing and Treatment Behaviors
Among HIV-Positive Adults in North West Province, South Africa. AIDS Behav. 2018.
PLOS ONE HIV testing and care among MSM and transgender individuals in Johannesburg
PLOS ONE | https://doi.org/10.1371/journal.pone.0234384 June 17, 2020 19 / 19
